Genetic Testing of Children for Late Onset Disease

UNCG Author/Contributor (non-UNCG co-authors, if there are any, appear on document)
Terrance C. McConnell, Professor (Creator)
The University of North Carolina at Greensboro (UNCG )
Web Site:

Abstract: Over the past decade, genetic tests have become available for a wide variety of disorders. As a result we are able to predict, with some degree of certainty, whether or not an individual will develop such diseases as breast cancer, Huntington’s disease, polycystic kidney disease, and familial adenomatous polyposis. The ability to predict disease poses several unique ethical considerations for clinical decision making regarding the provision of genetic testing. Patients must be able to comprehend the complexities of genetic testing and the potential meaning of the results. Patients must consider the emotional, social, and economic consequences of revelations regarding their risk status. Also, obtaining information on risk status may have implications for persons other than the individual seeking genetic testing.

Additional Information

Sevick MA, Nativio DG, McConnell T (2005) Genetic Testing of Children for Late Onset Disease. Cambridge Quarterly of Healthcare Ethics 14(1) (January 2005), pp. 47-56
Language: English
Date: 2005
Genetic testing, Ethical aspects, Hereditary illness

Email this document to